{
  "success": true,
  "data": {
    "id": 90577608,
    "linkedin_source_id": "81917876",
    "name": "OpenEvidence",
    "created_at": "2023-03-17",
    "last_updated": "2025-10-14",
    "websites_main": "https://openevidence.com",
    "websites_resolved": "https://www.openevidence.com/about",
    "websites_main_original": "https://www.openevidence.com/about",
    "unique_website": true,
    "unique_domain": true,
    "expired_domain": false,
    "websites_linkedin": "https://www.linkedin.com/company/xyla-ai",
    "websites_linkedin_canonical": "https://www.linkedin.com/company/openevidence",
    "social_linkedin_urls": [
      "https://www.linkedin.com/company/openevidence/"
    ],
    "websites_facebook": null,
    "social_facebook_urls": null,
    "websites_twitter": null,
    "social_twitter_urls": [
      "https://twitter.com/intent/follow?&screen_name=evidenceopen"
    ],
    "social_x_urls": null,
    "social_instagram_urls": null,
    "social_youtube_urls": null,
    "social_github_urls": null,
    "social_reddit_urls": null,
    "social_discord_urls": null,
    "social_pinterest_urls": null,
    "social_tiktok_urls": null,
    "logo": "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",
    "enriched_b2b": 1,
    "ticker": null,
    "exchange": null,
    "description": "Launched during the Mayo Clinic Platform Accelerate program, backed by Sequoia and Google, and an official Content Partner of the New England Journal of Medicine and The Journal of the American Medical Association OpenEvidence is the world\u2019s leading medical information platform.",
    "enriched_summary": "OpenEvidence is a Mayo clinic platform accelerate company that provides an AI-powered medical search platform.",
    "metadata_title": "OpenEvidence",
    "metadata_description": "The world's leading AI-powered medical search platform.",
    "industry": "Software Development",
    "specialities": null,
    "enriched_keywords": [
      "Mayo clinic",
      "Mayo clinic platform",
      "AI-powered",
      "medical search",
      "medical advisory board"
    ],
    "enriched_category": "Healthcare",
    "type": "Privately Held",
    "founded": "2021",
    "size_range": "11-50 employees",
    "size_employees_count": 69,
    "size_employees_count_inferred": 55,
    "followers": 19009,
    "location_hq_raw_address": "Miami, Florida, United States",
    "location_hq_country": "United States",
    "location_hq_regions": [
      "Northern America",
      "Northern America",
      "AMER"
    ],
    "locations_full": [
      {
        "location_address": "215 NW 24th St; Miami, Florida 33127, US",
        "is_primary": true
      },
      {
        "location_address": "577 2nd St; San Francisco, California 94107, US",
        "is_primary": false
      }
    ],
    "updates": [
      {
        "followers": 19009,
        "date": "5d",
        "description": "Thank you, Jensen Huang, for the OpenEvidence callout on CNBC. NVIDIA is the fountainhead of our entire industry, and we\u2019re honored to be included among your examples of what\u2019s working in AI.",
        "reactions_count": 112,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 19009,
        "date": "1w",
        "description": "OpenEvidence is at AAFP FMX Conference!\n\nCome see us at booth #1642 for coffee and to learn more about how OpenEvidence is transforming evidence-based clinical decision-making for family medicine. \n\nThere will be a special announcement at the main stage on Tuesday, October 7th, in the afternoon.\n\n#AAFPFMX #OpenEvidence #Healthcare",
        "reactions_count": 21,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 19009,
        "date": "1w",
        "description": "OpenEvidence featured on Bloomberg TV. \ud83c\udfa5\nOncologist Dr. Mullangi sits down with Bloomberg to share how she uses OpenEvidence in daily practice. \ud83d\udd0a Sound on. Watch the segment.",
        "reactions_count": 91,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 19009,
        "date": "1w",
        "description": "Last week, OpenEvidence hosted our inaugural keynote event, \"Medical Search in the AI Era\"\u00a0at Google HQ in NYC \u2014 bringing together physician leaders and healthcare innovators to explore how AI is reshaping medicine.\n\nThank you to Google\u2019s Dr. Peter Clardy, for joining our founder, Daniel Nadler, on stage for a fireside chat on the changes AI is bringing to the industry. And to our physician panel, Eric Collisson, MD, Vishal Patel, MD and Vivek Rudrapatna, MD (and moderator Travis Zack, MD, PhD) who talked about what those changes mean for their practice day to day. \n\nSpecial thanks to Sangeen Zeb and the Google Ventures team for your partnership!",
        "reactions_count": 88,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 19009,
        "date": "2w",
        "description": "OpenEvidence is at DCI Network's \"Signal Through The Noise: What Works, What Lasts, and What Matters in Healthcare AI\" conference. \n\nJoin us on Friday to learn more about how OpenEvidence is transforming evidence-based clinical decision-making, as well as a special announcement.\n\n#DCINetwork #OpenEvidence #Healthcare",
        "reactions_count": 25,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 19009,
        "date": "2w",
        "description": "Profile of the \u201cother investor from Omaha,\u201d GV (Google Ventures) Partner and OpenEvidence backer, Sangeen Zeb. Our internal code name for him is \u201cBrother Missouri,\u201d because as steadily, reliably, and dependably as the Missouri River flows unbroken along Omaha\u2019s edge, Sangeen will be there for you like a brother\u2014no matter the hour of day and no matter what you need.\n\nhttps://lnkd.in/gF3X4hZB",
        "reactions_count": 43,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 141723,
        "date": "1mo",
        "description": "Big news: Open Evidence just became the first AI to score a perfect 100% on the US Medical Licensing Exam. \n\nOpenEvidence\u2019s AI scored a perfect 100% on the U.S. Medical Licensing Exam, answering every question correctly and explaining the reasoning, citing gold-standard medical sources. Over 40% of U.S. physicians are currently using OpenEvidence for evidence-based clinical decision-making and practice support.\n\nTheir next project? Helping students. The team is now developing tools to help medical students learn, test, and apply clinical knowledge at school with the same sources trusted by practicing physicians.\n\nWe\u2019re proud to support OpenEvidence as they help shape the future of medical care, and soon education. Congratulations to Daniel Nadler and the team on this incredible milestone!",
        "reactions_count": 387,
        "comments_count": 20,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 19009,
        "date": "1mo",
        "description": "Today our team launched\u00a0OpenEvidence Visits, a new feature aimed at assisting clinicians with their patient encounters in real-time. Visits acts as a digital Clinical Assistant that enriches encounter notes with the latest clinical evidence and guidelines, assists with clinical documentation, and allows physicians to manage patient documents and ask OpenEvidence questions using the entire context of their patients' history and documentation.\n\nOpenEvidence Visits is free for all verified US Healthcare Professionals. Read more about it here:\u00a0 https://lnkd.in/e7Q8pt7t",
        "reactions_count": 255,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 19009,
        "date": "2mo",
        "description": "OpenEvidence will be at AAFP FUTURE this week!\n\nStop by booth 911 for free coffee and to learn more about OpenEvidence from the team. \n\n#AAFP #FUTURE2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 40,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 19009,
        "date": "3mo",
        "description": "Join us for an interactive webinar introducing OpenEvidence, your new clinical support tool. \n\nDesigned for all clinicians including attendings, medical students and residents, this session will demonstrate how OpenEvidence can support evidence-based decision-making, streamline your workflow, and enhance confidence on the wards.\n\nWhether you are starting your clerkships or preparing for day one of residency, discover how OpenEvidence helps you think faster, stay current, and make smarter clinical decisions\u2014right when you need it most.\n\nAll medical students who attend and register with a valid U.S. institutional email will receive 1 month of unlimited access to OpenEvidence.\n\nRegister here: https://lnkd.in/gj3SuMgF",
        "reactions_count": 83,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 18598,
        "date": "2d",
        "description": "OpenEvidence featured on Bloomberg TV. \ud83c\udfa5\nOncologist Dr. Mullangi sits down with Bloomberg to share how she uses OpenEvidence in daily practice. \ud83d\udd0a Sound on. Watch the segment.",
        "reactions_count": 66,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 18598,
        "date": "4h",
        "description": "Thank you, Jensen Huang, for the OpenEvidence callout on CNBC. NVIDIA is the fountainhead of our entire industry, and we\u2019re honored to be included among your examples of what\u2019s working in AI.",
        "reactions_count": 42,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 18598,
        "date": "2d",
        "description": "OpenEvidence is at AAFP FMX Conference!\n\nCome see us at booth #1642 for coffee and to learn more about how OpenEvidence is transforming evidence-based clinical decision-making for family medicine. \n\nThere will be a special announcement at the main stage on Tuesday, October 7th, in the afternoon.\n\n#AAFPFMX #OpenEvidence #Healthcare",
        "reactions_count": 18,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 18598,
        "date": "1w",
        "description": "Last week, OpenEvidence hosted our inaugural keynote event, \"Medical Search in the AI Era\"\u00a0at Google HQ in NYC \u2014 bringing together physician leaders and healthcare innovators to explore how AI is reshaping medicine.\n\nThank you to Google\u2019s Dr. Peter Clardy, for joining our founder, Daniel Nadler, on stage for a fireside chat on the changes AI is bringing to the industry. And to our physician panel, Eric Collisson, MD, Vishal Patel, MD and Vivek Rudrapatna, MD (and moderator Travis Zack, MD, PhD) who talked about what those changes mean for their practice day to day. \n\nSpecial thanks to Sangeen Zeb and the Google Ventures team for your partnership!",
        "reactions_count": 82,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 18598,
        "date": "2w",
        "description": "OpenEvidence is at DCI Network's \"Signal Through The Noise: What Works, What Lasts, and What Matters in Healthcare AI\" conference. \n\nJoin us on Friday to learn more about how OpenEvidence is transforming evidence-based clinical decision-making, as well as a special announcement.\n\n#DCINetwork #OpenEvidence #Healthcare",
        "reactions_count": 24,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 18598,
        "date": "2w",
        "description": "Profile of the \u201cother investor from Omaha,\u201d GV (Google Ventures) Partner and OpenEvidence backer, Sangeen Zeb. Our internal code name for him is \u201cBrother Missouri,\u201d because as steadily, reliably, and dependably as the Missouri River flows unbroken along Omaha\u2019s edge, Sangeen will be there for you like a brother\u2014no matter the hour of day and no matter what you need.\n\nhttps://lnkd.in/gF3X4hZB",
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 141418,
        "date": "1mo",
        "description": "Big news: Open Evidence just became the first AI to score a perfect 100% on the US Medical Licensing Exam. \n\nOpenEvidence\u2019s AI scored a perfect 100% on the U.S. Medical Licensing Exam, answering every question correctly and explaining the reasoning, citing gold-standard medical sources. Over 40% of U.S. physicians are currently using OpenEvidence for evidence-based clinical decision-making and practice support.\n\nTheir next project? Helping students. The team is now developing tools to help medical students learn, test, and apply clinical knowledge at school with the same sources trusted by practicing physicians.\n\nWe\u2019re proud to support OpenEvidence as they help shape the future of medical care, and soon education. Congratulations to Daniel Nadler and the team on this incredible milestone!",
        "reactions_count": 381,
        "comments_count": 20,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 18598,
        "date": "1mo",
        "description": "Today our team launched\u00a0OpenEvidence Visits, a new feature aimed at assisting clinicians with their patient encounters in real-time. Visits acts as a digital Clinical Assistant that enriches encounter notes with the latest clinical evidence and guidelines, assists with clinical documentation, and allows physicians to manage patient documents and ask OpenEvidence questions using the entire context of their patients' history and documentation.\n\nOpenEvidence Visits is free for all verified US Healthcare Professionals. Read more about it here:\u00a0 https://lnkd.in/e7Q8pt7t",
        "reactions_count": 254,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 18598,
        "date": "2mo",
        "description": "OpenEvidence will be at AAFP FUTURE this week!\n\nStop by booth 911 for free coffee and to learn more about OpenEvidence from the team. \n\n#AAFP #FUTURE2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 40,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 18598,
        "date": "3mo",
        "description": "Join us for an interactive webinar introducing OpenEvidence, your new clinical support tool. \n\nDesigned for all clinicians including attendings, medical students and residents, this session will demonstrate how OpenEvidence can support evidence-based decision-making, streamline your workflow, and enhance confidence on the wards.\n\nWhether you are starting your clerkships or preparing for day one of residency, discover how OpenEvidence helps you think faster, stay current, and make smarter clinical decisions\u2014right when you need it most.\n\nAll medical students who attend and register with a valid U.S. institutional email will receive 1 month of unlimited access to OpenEvidence.\n\nRegister here: https://lnkd.in/gj3SuMgF",
        "reactions_count": 83,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 138381,
        "date": "3w",
        "description": "Big news: Open Evidence just became the first AI to score a perfect 100% on the US Medical Licensing Exam. \n\nOpenEvidence\u2019s AI scored a perfect 100% on the U.S. Medical Licensing Exam, answering every question correctly and explaining the reasoning, citing gold-standard medical sources. Over 40% of U.S. physicians are currently using OpenEvidence for evidence-based clinical decision-making and practice support.\n\nTheir next project? Helping students. The team is now developing tools to help medical students learn, test, and apply clinical knowledge at school with the same sources trusted by practicing physicians.\n\nWe\u2019re proud to support OpenEvidence as they help shape the future of medical care, and soon education. Congratulations to Daniel Nadler and the team on this incredible milestone!",
        "reactions_count": 279,
        "comments_count": 17,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 16234,
        "date": "2w",
        "description": "Today our team launched\u00a0OpenEvidence Visits, a new feature aimed at assisting clinicians with their patient encounters in real-time. Visits acts as a digital Clinical Assistant that enriches encounter notes with the latest clinical evidence and guidelines, assists with clinical documentation, and allows physicians to manage patient documents and ask OpenEvidence questions using the entire context of their patients' history and documentation.\n\nOpenEvidence Visits is free for all verified US Healthcare Professionals. Read more about it here:\u00a0 https://lnkd.in/e7Q8pt7t",
        "reactions_count": 188,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 16234,
        "date": "1mo",
        "description": "OpenEvidence will be at AAFP FUTURE this week!\n\nStop by booth 911 for free coffee and to learn more about OpenEvidence from the team. \n\n#AAFP #FUTURE2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 39,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 16234,
        "date": "2mo",
        "description": "Join us for an interactive webinar introducing OpenEvidence, your new clinical support tool. \n\nDesigned for all clinicians including attendings, medical students and residents, this session will demonstrate how OpenEvidence can support evidence-based decision-making, streamline your workflow, and enhance confidence on the wards.\n\nWhether you are starting your clerkships or preparing for day one of residency, discover how OpenEvidence helps you think faster, stay current, and make smarter clinical decisions\u2014right when you need it most.\n\nAll medical students who attend and register with a valid U.S. institutional email will receive 1 month of unlimited access to OpenEvidence.\n\nRegister here: https://lnkd.in/gj3SuMgF",
        "reactions_count": 79,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 16234,
        "date": "3mo",
        "description": "OpenEvidence will be at the ASCO Annual Meeting next week!\n\nStop by booth 15159 for free coffee and to learn more about OpenEvidence from the team.\n\n#ASCO2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 36,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 16234,
        "date": "4mo",
        "description": "OpenEvidence Named to Forbes AI 50",
        "reactions_count": 59,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 16234,
        "date": "8mo",
        "description": null,
        "reactions_count": 28,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 137652,
        "date": "1w",
        "description": "Big news: Open Evidence just became the first AI to score a perfect 100% on the US Medical Licensing Exam. \n\nOpenEvidence\u2019s AI scored a perfect 100% on the U.S. Medical Licensing Exam, answering every question correctly and explaining the reasoning, citing gold-standard medical sources. Over 40% of U.S. physicians are currently using OpenEvidence for evidence-based clinical decision-making and practice support.\n\nTheir next project? Helping students. The team is now developing tools to help medical students learn, test, and apply clinical knowledge at school with the same sources trusted by practicing physicians.\n\nWe\u2019re proud to support OpenEvidence as they help shape the future of medical care, and soon education. Congratulations to Daniel Nadler and the team on this incredible milestone!",
        "reactions_count": 231,
        "comments_count": 17,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 15299,
        "date": "5d",
        "description": "Today our team launched\u00a0OpenEvidence Visits, a new feature aimed at assisting clinicians with their patient encounters in real-time. Visits acts as a digital Clinical Assistant that enriches encounter notes with the latest clinical evidence and guidelines, assists with clinical documentation, and allows physicians to manage patient documents and ask OpenEvidence questions using the entire context of their patients' history and documentation.\n\nOpenEvidence Visits is free for all verified US Healthcare Professionals. Read more about it here:\u00a0 https://lnkd.in/e7Q8pt7t",
        "reactions_count": 132,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 15299,
        "date": "3w",
        "description": "OpenEvidence will be at AAFP FUTURE this week!\n\nStop by booth 911 for free coffee and to learn more about OpenEvidence from the team. \n\n#AAFP #FUTURE2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 36,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 15299,
        "date": "2mo",
        "description": "Join us for an interactive webinar introducing OpenEvidence, your new clinical support tool. \n\nDesigned for all clinicians including attendings, medical students and residents, this session will demonstrate how OpenEvidence can support evidence-based decision-making, streamline your workflow, and enhance confidence on the wards.\n\nWhether you are starting your clerkships or preparing for day one of residency, discover how OpenEvidence helps you think faster, stay current, and make smarter clinical decisions\u2014right when you need it most.\n\nAll medical students who attend and register with a valid U.S. institutional email will receive 1 month of unlimited access to OpenEvidence.\n\nRegister here: https://lnkd.in/gj3SuMgF",
        "reactions_count": 76,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 15299,
        "date": "3mo",
        "description": "OpenEvidence will be at the ASCO Annual Meeting next week!\n\nStop by booth 15159 for free coffee and to learn more about OpenEvidence from the team.\n\n#ASCO2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 35,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 15299,
        "date": "4mo",
        "description": "OpenEvidence Named to Forbes AI 50",
        "reactions_count": 58,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 15299,
        "date": "8mo",
        "description": null,
        "reactions_count": 27,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 13812,
        "date": "1w",
        "description": "OpenEvidence will be at AAFP FUTURE this week!\n\nStop by booth 911 for free coffee and to learn more about OpenEvidence from the team. \n\n#AAFP #FUTURE2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 31,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 13812,
        "date": "1mo",
        "description": "Join us for an interactive webinar introducing OpenEvidence, your new clinical support tool. \n\nDesigned for all clinicians including attendings, medical students and residents, this session will demonstrate how OpenEvidence can support evidence-based decision-making, streamline your workflow, and enhance confidence on the wards.\n\nWhether you are starting your clerkships or preparing for day one of residency, discover how OpenEvidence helps you think faster, stay current, and make smarter clinical decisions\u2014right when you need it most.\n\nAll medical students who attend and register with a valid U.S. institutional email will receive 1 month of unlimited access to OpenEvidence.\n\nRegister here: https://lnkd.in/gj3SuMgF",
        "reactions_count": 76,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 13812,
        "date": "2mo",
        "description": "OpenEvidence will be at the ASCO Annual Meeting next week!\n\nStop by booth 15159 for free coffee and to learn more about OpenEvidence from the team.\n\n#ASCO2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 34,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 13812,
        "date": "3mo",
        "description": "OpenEvidence Named to Forbes AI 50",
        "reactions_count": 52,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 13812,
        "date": "7mo",
        "description": null,
        "reactions_count": 27,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 13052,
        "date": "6d",
        "description": "OpenEvidence will be at AAFP FUTURE this week!\n\nStop by booth 911 for free coffee and to learn more about OpenEvidence from the team. \n\n#AAFP #FUTURE2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 30,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 13052,
        "date": "1mo",
        "description": "Join us for an interactive webinar introducing OpenEvidence, your new clinical support tool. \n\nDesigned for all clinicians including attendings, medical students and residents, this session will demonstrate how OpenEvidence can support evidence-based decision-making, streamline your workflow, and enhance confidence on the wards.\n\nWhether you are starting your clerkships or preparing for day one of residency, discover how OpenEvidence helps you think faster, stay current, and make smarter clinical decisions\u2014right when you need it most.\n\nAll medical students who attend and register with a valid U.S. institutional email will receive 1 month of unlimited access to OpenEvidence.\n\nRegister here: https://lnkd.in/gj3SuMgF",
        "reactions_count": 73,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 13052,
        "date": "2mo",
        "description": "OpenEvidence will be at the ASCO Annual Meeting next week!\n\nStop by booth 15159 for free coffee and to learn more about OpenEvidence from the team.\n\n#ASCO2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 33,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 13052,
        "date": "3mo",
        "description": "OpenEvidence Named to Forbes AI 50",
        "reactions_count": 49,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 13052,
        "date": "7mo",
        "description": null,
        "reactions_count": 25,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 11900,
        "date": "1mo",
        "description": "Join us for an interactive webinar introducing OpenEvidence, your new clinical support tool. \n\nDesigned for all clinicians including attendings, medical students and residents, this session will demonstrate how OpenEvidence can support evidence-based decision-making, streamline your workflow, and enhance confidence on the wards.\n\nWhether you are starting your clerkships or preparing for day one of residency, discover how OpenEvidence helps you think faster, stay current, and make smarter clinical decisions\u2014right when you need it most.\n\nAll medical students who attend and register with a valid U.S. institutional email will receive 1 month of unlimited access to OpenEvidence.\n\nRegister here: https://lnkd.in/gj3SuMgF",
        "reactions_count": 68,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 11900,
        "date": "2mo",
        "description": "OpenEvidence will be at the ASCO Annual Meeting next week!\n\nStop by booth 15159 for free coffee and to learn more about OpenEvidence from the team.\n\n#ASCO2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 31,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 11900,
        "date": "3mo",
        "description": "OpenEvidence Named to Forbes AI 50",
        "reactions_count": 49,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 11900,
        "date": "7mo",
        "description": null,
        "reactions_count": 23,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 11407,
        "date": "4w",
        "description": "Join us for an interactive webinar introducing OpenEvidence, your new clinical support tool. \n\nDesigned for all clinicians including attendings, medical students and residents, this session will demonstrate how OpenEvidence can support evidence-based decision-making, streamline your workflow, and enhance confidence on the wards.\n\nWhether you are starting your clerkships or preparing for day one of residency, discover how OpenEvidence helps you think faster, stay current, and make smarter clinical decisions\u2014right when you need it most.\n\nAll medical students who attend and register with a valid U.S. institutional email will receive 1 month of unlimited access to OpenEvidence.\n\nRegister here: https://lnkd.in/gj3SuMgF",
        "reactions_count": 65,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 11407,
        "date": "2mo",
        "description": "OpenEvidence will be at the ASCO Annual Meeting next week!\n\nStop by booth 15159 for free coffee and to learn more about OpenEvidence from the team.\n\n#ASCO2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 30,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 11407,
        "date": "3mo",
        "description": "OpenEvidence Named to Forbes AI 50",
        "reactions_count": 47,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 11407,
        "date": "7mo",
        "description": null,
        "reactions_count": 23,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 7211,
        "date": "2w",
        "description": "Join us for an interactive webinar introducing OpenEvidence, your new clinical support tool. \n\nDesigned for all clinicians including attendings, medical students and residents, this session will demonstrate how OpenEvidence can support evidence-based decision-making, streamline your workflow, and enhance confidence on the wards.\n\nWhether you are starting your clerkships or preparing for day one of residency, discover how OpenEvidence helps you think faster, stay current, and make smarter clinical decisions\u2014right when you need it most.\n\nAll medical students who attend and register with a valid U.S. institutional email will receive 1 month of unlimited access to OpenEvidence.\n\nRegister here: https://lnkd.in/gj3SuMgF",
        "reactions_count": 29,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 7211,
        "date": "1mo",
        "description": "OpenEvidence will be at the ASCO Annual Meeting next week!\n\nStop by booth 15159 for free coffee and to learn more about OpenEvidence from the team.\n\n#ASCO2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 26,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 7211,
        "date": "2mo",
        "description": "OpenEvidence Named to Forbes AI 50",
        "reactions_count": 40,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 7211,
        "date": "6mo",
        "description": null,
        "reactions_count": 18,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 5429,
        "date": "2w",
        "description": "OpenEvidence will be at the ASCO Annual Meeting next week!\n\nStop by booth 15159 for free coffee and to learn more about OpenEvidence from the team.\n\n#ASCO2025 #OpenEvidence #Healthcare #Innovation",
        "reactions_count": 23,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 5429,
        "date": "1mo",
        "description": "OpenEvidence Named to Forbes AI 50",
        "reactions_count": 35,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 5429,
        "date": "5mo",
        "description": null,
        "reactions_count": 16,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 4694,
        "date": "4w",
        "description": "OpenEvidence Named to Forbes AI 50",
        "reactions_count": 27,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 4694,
        "date": "4mo",
        "description": null,
        "reactions_count": 11,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 3937,
        "date": "1w",
        "description": "OpenEvidence Named to Forbes AI 50",
        "reactions_count": 17,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 3937,
        "date": "3w",
        "description": "OpenEvidence is attending the ACP's Internal Medicine Meeting!\n\nCome meet the team, and learn about how OpenEvidence is helping organize the world\u2019s medical knowledge and making it more useful, open, accessible, and understandable to healthcare workers!\n\n#Healthcare #Innovation #IM2025",
        "reactions_count": 15,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 3937,
        "date": "2mo",
        "description": "OpenEvidence is attending SXSW!\n\nCome meet the team, and learn about how OpenEvidence is helping organize the world\u2019s medical knowledge and making it more useful, open, accessible, and understandable to healthcare workers!\n\n#Healthcare #Innovation #SXSW2025",
        "reactions_count": 18,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 3937,
        "date": "2mo",
        "description": "This month, the FDA approved the first xenotransplantation clinical trial. United Therapeutics will transplant kidneys from gene-edited pigs into participants with end-stage renal disease; the first xenotransplant of this trial is expected to occur in mid-2025. \n\nThese aren\u2019t the first kidneys from gene-edited pigs transplanted into living humans, but previous cases were done through compassionate use waivers. \n\nThis trial will explore the safety and efficacy of kidney xenografts, but how is success defined in the burgeoning field of xenotransplantation? Let's see what OpenEvidence says:\n\n\ud83d\udc49  https://lnkd.in/gDGwK445 \n\n#Healthcare #Innovation #Xenotransplant #GoBeyondTheHeadline",
        "reactions_count": 16,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 3937,
        "date": "3mo",
        "description": "OpenEvidence is attending CES! Come meet the team!. \n\nOpenEvidence is here to organize the world\u2019s medical knowledge and make it more useful, open, accessible, and understandable! \n#Healthcare #Innovation #CES2025\n\nIf you would like to connect, message us here on LinkedIn or email andrew@openevidence.com.",
        "reactions_count": 7,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 3937,
        "date": "4mo",
        "description": null,
        "reactions_count": 5,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": "OpenEvidence is attending CES! Come meet the team!. \n\nOpenEvidence is here to organize the world\u2019s medical knowledge and make it more useful, open, accessible, and understandable! \n#Healthcare #Innovation #CES2025\n\nIf you would like to connect, message us here on LinkedIn or email andrew@openevidence.com.",
        "reactions_count": 5,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": null,
        "reactions_count": 2,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2w",
        "description": "OpenEvidence is attending CES! Come meet the team!. \n\nOpenEvidence is here to organize the world\u2019s medical knowledge and make it more useful, open, accessible, and understandable! \n#Healthcare #Innovation #CES2025\n\nIf you would like to connect, message us here on LinkedIn or email andrew@openevidence.com.",
        "reactions_count": 4,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": null,
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "6d",
        "description": "OpenEvidence is attending CES! Come meet the team!. \n\nOpenEvidence is here to organize the world\u2019s medical knowledge and make it more useful, open, accessible, and understandable! \n#Healthcare #Innovation #CES2025\n\nIf you would like to connect, message us here on LinkedIn or email andrew@openevidence.com.",
        "reactions_count": 4,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "3w",
        "description": null,
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "11mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 97,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "10mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 94,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "9mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 93,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "8mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 93,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "7mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 92,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "12mo",
        "description": "Love working with Large Language Models (LLMs) but also want to help people and have an impact? Reach out: careers[at]OpenEvidence[dot]com",
        "reactions_count": 253,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "12mo",
        "description": null,
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "6mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 91,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "10mo",
        "description": "Love working with Large Language Models (LLMs) but also want to help people and have an impact? Reach out: careers[at]OpenEvidence[dot]com",
        "reactions_count": 253,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "10mo",
        "description": null,
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "5mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 90,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "4mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 90,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "9mo",
        "description": "Love working with Large Language Models (LLMs) but also want to help people and have an impact? Reach out: careers[at]OpenEvidence[dot]com",
        "reactions_count": 253,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "9mo",
        "description": null,
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "3mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 90,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "8mo",
        "description": "Love working with Large Language Models (LLMs) but also want to help people and have an impact? Reach out: careers[at]OpenEvidence[dot]com",
        "reactions_count": 253,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "8mo",
        "description": null,
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 89,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "7mo",
        "description": "Love working with Large Language Models (LLMs) but also want to help people and have an impact? Reach out: careers[at]OpenEvidence[dot]com",
        "reactions_count": 253,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "7mo",
        "description": null,
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 85,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "6mo",
        "description": "Love working with Large Language Models (LLMs) but also want to help people and have an impact? Reach out: careers[at]OpenEvidence[dot]com",
        "reactions_count": 248,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "6mo",
        "description": null,
        "reactions_count": 38,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2w",
        "description": "OpenEvidence AI, the only AI to score above 90% on the U.S. Medical Licensing Examination (USMLE), is proud to announce that it is the AI engine powering Elsevier\u2019s ClinicalKey AI, combining Elsevier\u2019s trusted content (from The Lancet, Cell, and Gray\u2019s Anatomy right down to the most specialized journals and textbooks) with OpenEvidence\u2019s USMLE record-setting, responsible AI. \n\nFor a free early-access preview of the future of AI clinical decision support, contact access@openevidence.com with your name and institutional affiliation.",
        "reactions_count": 80,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "4mo",
        "description": "Love working with Large Language Models (LLMs) but also want to help people and have an impact? Reach out: careers[at]OpenEvidence[dot]com",
        "reactions_count": 220,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "4mo",
        "description": null,
        "reactions_count": 37,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "3mo",
        "description": "Love working with Large Language Models (LLMs) but also want to help people and have an impact? Reach out: careers[at]OpenEvidence[dot]com",
        "reactions_count": 226,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      }
    ],
    "funding_rounds": [
      {
        "last_round_investors_count": 2,
        "total_rounds_count": 4,
        "last_round_type": "Series B",
        "last_round_date": "2025-08-15",
        "last_round_money_raised": 210000000,
        "cb_url": "https://www.crunchbase.com/funding_round/openevidence-series-b--69b63ed8"
      }
    ],
    "technologies": null,
    "phone_numbers": [],
    "emails": [],
    "pricing_available": false,
    "free_trial_available": false,
    "demo_available": false,
    "is_downloadable": false,
    "mobile_apps_exist": false,
    "online_reviews_exist": false,
    "api_docs_exist": false
  },
  "status_code": 200
}